TLR4 and Friedreich ataxia: In this study, we showed that ibudilast, a TLR4 blocker, improved the damaged renal function in mice with FA-induced AKI by blocking TLR4 activation, serving as a therapeutic option that induces anti-inflammatory mechanisms.